Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009 Nov) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 253(2):486–496. https://doi.org/10.1148/radiol.2532090007
Article
PubMed
PubMed Central
Google Scholar
Blasel S, Zagorcic A, Jurcoane A, Bähr O, Wagner M, Harter PN, Hattingen E (2016 Jan) Perfusion MRI in the evaluation of suspected glioblastoma recurrence. Journal of Neuroimaging. 26(1):116–123. https://doi.org/10.1111/jon.12247
Article
PubMed
Google Scholar
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G (2008 May 1) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. Journal of Clinical Oncology. 26(13):2192–2197. https://doi.org/10.1200/JCO.2007.14.8163
Article
PubMed
Google Scholar
Deuschl C, Kirchner J, Poeppel TD, Schaarschmidt B, Kebir S, El Hindy N, Hense J, Quick HH, Glas M, Herrmann K, Umutlu L (2018) 11 C–MET PET/MRI for detection of recurrent glioma. European journal of nuclear medicine and molecular imaging. 45(4):593–601. https://doi.org/10.1007/s00259-017-3916-9
Article
CAS
PubMed
Google Scholar
van Dijken BR, van Laar PJ, Smits M, Dankbaar JW, Enting RH, van der Hoorn A (2019 Jan) Perfusion MRI in treatment evaluation of glioblastomas: clinical relevance of current and future techniques. Journal of Magnetic Resonance Imaging. 49(1):11–22. https://doi.org/10.1002/jmri.26306
Article
PubMed
Google Scholar
Filss CP, Galldiks N, Stoffels G, Sabel M, Wittsack HJ, Turowski B, Antoch G, Zhang K, Fink GR, Coenen HH, Shah NJ (2014 Apr 1) Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors. Journal of Nuclear Medicine. 55(4):540–545. https://doi.org/10.2967/jnumed.113.129007
Article
CAS
PubMed
Google Scholar
Norbert Galldiks, Philipp Lohmann, Nathalie L Albert, Jörg C Tonn, Karl-Josef Langen, Current status of PET imaging in neuro-oncology, Neuro-Oncology Advances, Volume 1, Issue 1, May-December 2019,vdz 010.
Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel J, Schneider T, Woo KM, Zhang Z, Peck KK, Beal K (2016 Jun 1) A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro-oncology. 18(6):873–880. https://doi.org/10.1093/neuonc/nov301
Article
CAS
PubMed
Google Scholar
Heiss WD, Raab P, Lanfermann H (2011 Oct 1) Multimodality assessment of brain tumors and tumor recurrence. Journal of Nuclear Medicine. 52(10):1585–1600. https://doi.org/10.2967/jnumed.110.084210
Article
CAS
PubMed
Google Scholar
Hustinx R, Pourdehnad M, Kaschten B, Alavi A (2005) PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiologic Clinics. 43(1):35–47. https://doi.org/10.1016/j.rcl.2004.09.009
Article
PubMed
Google Scholar
Jena A, Taneja S, Jha A, Damesha NK, Negi P, Jadhav GK, Verma SM, Sogani SK (2017) Multiparametric evaluation in differentiating glioma recurrence from treatment-induced necrosis using simultaneous 18F-FDG-PET/MRI: a single-institution retrospective study. American Journal of Neuroradiology. 38(5):899–907. https://doi.org/10.3174/ajnr.A5124
Article
CAS
PubMed
PubMed Central
Google Scholar
Keunen O, Taxt T, Grüner R, Lund-Johansen M, Tonn JC, Pavlin T, Bjerkvig R, Niclou SP, Thorsen F (2014 Sep 30) Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. Advanced drug delivery reviews. 76:98–115. https://doi.org/10.1016/j.addr.2014.07.010
Article
CAS
PubMed
Google Scholar
Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH (2010 Nov 1) Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Clinical neurology and neurosurgery. 112(9):758–765. https://doi.org/10.1016/j.clineuro.2010.06.005
Article
PubMed
Google Scholar
Minamimoto R, Saginoya T, Kondo C, Tomura N, Ito K, Matsuo Y, Matsunaga S, Shuto T, Akabane A, Miyata Y, Sakai S (2015) Differentiation of brain tumor recurrence from post-radiotherapy necrosis with 11 C-methionine PET: visual assessment versus quantitative assessment. PloS one. 10(7):e0132515. https://doi.org/10.1371/journal.pone.0132515
Article
CAS
PubMed
PubMed Central
Google Scholar
Nael K, Bauer AH, Hormigo A, Lemole M, Germano IM, Puig J, Stea B (2018 Jan) Multiparametric MRI for differentiation of radiation necrosis from recurrent tumor in patients with treated glioblastoma. American Journal of Roentgenology. 210(1):18–23. https://doi.org/10.2214/AJR.17.18003
Article
PubMed
Google Scholar
Nihashi T, Dahabreh IJ, Terasawa T (2013 May 1) Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. American Journal of Neuroradiology. 34(5):944–950. https://doi.org/10.3174/ajnr.A3324
Article
CAS
PubMed
PubMed Central
Google Scholar
Nozawa A, Rivandi AH, Kanematsu M, Hoshi H, Piccioni D, Kesari S, Hoh CK (2015 Jun) Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes. Nuclear medicine communications. 36(6):573–581. https://doi.org/10.1097/MNM.0000000000000288
Article
CAS
PubMed
PubMed Central
Google Scholar
Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K, Kowada M (1991 May) Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiologica. 32(3):197–202. https://doi.org/10.1177/028418519103200302
Article
CAS
PubMed
Google Scholar
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018 Oct 1) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-oncology 20(suppl_4):iv1–i86
Article
Google Scholar
Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, Gonzalez RG, Lev MH (2010 Mar 1) Glioma recurrence versus radiation necrosis?: A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Academic radiology. 17(3):282–290. https://doi.org/10.1016/j.acra.2009.10.024
Article
PubMed
Google Scholar
Qiao Z, Zhao X, Wang K, Zhang Y, Fan D, Yu T, Shen H, Chen Q, Ai L (2019 Feb 1) Utility of dynamic susceptibility contrast perfusion-weighted MR imaging and 11C-methionine PET/CT for differentiation of tumor recurrence from radiation injury in patients with high-grade gliomas. American Journal of Neuroradiology. 40(2):253–259. https://doi.org/10.3174/ajnr.A5952
Article
CAS
PubMed
PubMed Central
Google Scholar
Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? American Journal of Neuroradiology. 19(3):407–413
CAS
PubMed
PubMed Central
Google Scholar
Ronca R, Benkheil M, Mitola S, Struyf S, Liekens S (2017 Nov) Tumor angiogenesis revisited: regulators and clinical implications. Medicinal research reviews. 37(6):1231–1274. https://doi.org/10.1002/med.21452
Article
PubMed
Google Scholar
Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S (2013 Dec 1) Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Academic radiology. 20(12):1557–1565. https://doi.org/10.1016/j.acra.2013.09.003
Article
PubMed
Google Scholar
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC (2019 Apr) Integrated PET-MRI for glioma surveillance: perfusion-metabolism discordance rate and association with molecular profiling. American Journal of Roentgenology. 212(4):883–891. https://doi.org/10.2214/AJR.18.20531
Article
PubMed
Google Scholar
Soni N, Ora M, Mohindra N, Menda Y, Bathla G (2020 Sep 1) Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature. American Journal of Neuroradiology. 41(9):1550–1557. https://doi.org/10.3174/ajnr.A6685
Article
CAS
PubMed
Google Scholar
Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J (2005a Mar 10) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England journal of medicine. 352(10):987–996. https://doi.org/10.1056/NEJMoa043330
Article
CAS
Google Scholar
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005b;352:987–996. [PubMed: 15758009], 10, DOI: https://doi.org/10.1056/NEJMoa043330
Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M (2000 May 1) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. American Journal of Neuroradiology. 21(5):901–909
CAS
PubMed
PubMed Central
Google Scholar
Takenaka S, Asano Y, Shinoda J, Nomura Y, Yonezawa S, Miwa K, Yano H, Iwama T (2014) Comparison of 11C-methionine, 11C-choline, and 18F-fluorodeoxyglucose-positron emission tomography for distinguishing glioma recurrence from radiation necrosis. Neurologia medico-chirurgica. 54(4):280–289. https://doi.org/10.2176/nmc.oa2013-0117
Article
PubMed
Google Scholar
Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008 May 1) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Journal of Nuclear Medicine. 49(5):694–699. https://doi.org/10.2967/jnumed.107.048082
Article
PubMed
Google Scholar
Verma N, Cowperthwaite MC, Burnett MG, Markey MK (2013 May 1) Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro-oncology. 15(5):515–534. https://doi.org/10.1093/neuonc/nos307
Article
PubMed
PubMed Central
Google Scholar
Wang X, Hu X, Xie P, Li W, Li X, Ma L (2015 Jun) Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: a diagnostic meta-analysis. Asia-Pacific Journal of Clinical Oncology. 11(2):97–105. https://doi.org/10.1111/ajco.12202
Article
PubMed
Google Scholar
Wang S, Martinez-Lage M, Sakai Y, Chawla S, Kim SG, Alonso-Basanta M, Lustig RA, Brem S, Mohan S, Wolf RL, Desai A (2016 Jan 1) Differentiating tumor progression from pseudoprogression in patients with glioblastomas using diffusion tensor imaging and dynamic susceptibility contrast MRI. American Journal of Neuroradiology. 37(1):28–36. https://doi.org/10.3174/ajnr.A4474
Article
PubMed
PubMed Central
Google Scholar
Weathers SP, Gilbert MR (2015 Jul 1) Current challenges in designing GBM trials for immunotherapy. Journal of neuro-oncology. 123(3):331–337. https://doi.org/10.1007/s11060-015-1716-2
Article
CAS
PubMed
Google Scholar
Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ (2017 Jul 20) Response assessment in neuro-oncology clinical trials. Journal of Clinical Oncology. 35(21):2439–2449. https://doi.org/10.1200/JCO.2017.72.7511
Article
CAS
PubMed
PubMed Central
Google Scholar
Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI (2018 Oct) Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast media & molecular imaging. 2018:1–6. https://doi.org/10.1155/2018/6828396
Article
CAS
Google Scholar